BTG2 as a tumor target for the treatment of luminal A breast cancer

As one of the most common breast cancer subtypes, luminal A breast cancer is sensitive to endocrine-based therapy and insensitive to chemotherapy. Patients with luminal A subtype of breast cancer have a relatively good prognosis compared with that of patients with other subtypes of breast cancer. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Runzhi, Wang, Ronghua, Tian, Jinjun, Wang, Jian, Tang, Huaxiao, Wu, Tao, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988138/
https://www.ncbi.nlm.nih.gov/pubmed/35401805
http://dx.doi.org/10.3892/etm.2022.11269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988138/
https://www.ncbi.nlm.nih.gov/pubmed/35401805
http://dx.doi.org/10.3892/etm.2022.11269

Ejemplares similares